Work Here?
Mendaera
Work Here?
Healthcare technology for precise point-of-care interventions
Mendaera
Work Here?
Healthcare technology for precise point-of-care interventions
About Mendaera
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$94.4M
Headquarters
San Carlos, California
Founded
2020
Overview
Mendaera provides advanced technology solutions that enhance point-of-care interventions, allowing healthcare providers to perform medical procedures accurately at the patient's location. Their products aim to eliminate barriers in the patient journey, speed up recovery times, and reduce healthcare costs. Mendaera collaborates with hospitals, clinics, and payors to ensure their solutions deliver better value in patient care while meeting regulatory standards. The company's goal is to transform healthcare delivery through technology, improving patient outcomes and satisfaction.
Simplify's Take
What believers are saying
- $73M Series B funding accelerates robotics and AI technology development and market penetration.
- Eric Davidson's appointment as CCO enhances strategic growth and partnership opportunities.
- Support from Dr. Fred Moll provides industry insights and credibility for regulatory approvals.
What critics are saying
- Integration of Avail's telepresence tech may delay product rollouts or affect quality.
- Reliance on venture capital funding pressures Mendaera for quick returns, risking strategic missteps.
- Rapid AI and robotics advancements may outpace Mendaera's ability to keep up, risking obsolescence.
What makes Mendaera unique
- Mendaera integrates robotics, AI, and real-time imaging for precise point-of-care interventions.
- The company collaborates with EchoNous to enhance ultrasound-guided interventional procedures.
- Mendaera's acquisition of Avail Medsystems' telepresence technology boosts remote healthcare capabilities.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$94.4M
Above
Industry Average
Funded Over
2 Rounds
Founders FundIndustry standards
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↑ 8%2 year growth
↓ -5%Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.
Mendaera has secured $73M in venture capital to advance its handheld robotics platform for needle-based procedures like biopsy and vascular access. The Silicon Valley startup aims to address healthcare provider shortages and rising demand by integrating real-time imaging with robotic guidance. The Series B funding was led by Threshold Ventures, with participation from Lux Capital and others, to enhance patient care and expand access to high-quality medical procedures.
Portable ultrasound company EchoNous and AI and robotics company Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.
Mediwhale, an AI-powered health diagnostics company, raised $12 million in Series A2 funding led by Korea Development Bank, with participation from Woori Venture Partners, IMM Investment, and Mirae Asset Securities. The funds will enhance AI algorithms, seek U.S. FDA approval for Reti-CVD, expand globally, and develop new products. Movement Labs' partners raised $13.2 million, Tetrix secured $5 million, and Bot Auto raised $20 million in their respective funding rounds.
Mendaera announced $73 million Series B funding round led by Threshold Ventures to scale robotics and AI across mainstream medical procedures.
Mendaera is Hiring for 7 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Mendaera
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$94.4M
Headquarters
San Carlos, California
Founded
2020
Mendaera is Hiring for 7 Jobs on Simplify!
Find jobs on Simplify and start your career today